Literature DB >> 10445657

Financial incentives influencing the integration of mental health care and primary care.

R J Goldberg1.   

Abstract

Psychiatric problems are common in general medical practice and strongly influence utilization of medical care. Although several studies have demonstrated the positive clinical and financial impact of psychiatric interventions for medical patients, historic and economic forces have tended to maintain the separation of the primary health and mental health components of care. The author discusses the financial incentives that influence the success or failure of initiatives to integrate mental health care and primary care. Most models for financing care that use fee-for-service, carve-out, or capitated arrangements have done little to encourage collaborative treatment planning and coordination of care or have created conditions that work against such integration. True financial incentives for integration of psychiatric and primary health care are provided only by a shared-risk model of capitation-a model that has long existed in staff-model health maintenance organizations. This model increases motivation to lower overall utilization of care, improve patients' overall health status, and search for more effective models of care.

Entities:  

Mesh:

Year:  1999        PMID: 10445657     DOI: 10.1176/ps.50.8.1071

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  Rebuilding Family Relationship Competencies as a Primary Health Intervention.

Authors:  Brenda Reiss-Brennan; David Oppenheim; Judith L. Kirstein
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-04

2.  The challenge of integrated care for mental health: leaving the 50 minute hour and other sacred things.

Authors:  Andrew S Pomerantz; John A Corson; Mark J Detzer
Journal:  J Clin Psychol Med Settings       Date:  2009-01-31

3.  Primary care reform and service use by people with serious mental illness in Ontario.

Authors:  Leah S Steele; Anna Durbin; Elizabeth Lin; J Charles Victor; Julie Klein-Geltink; Richard H Glazier; Brandon Zagorski; Alexander Kopp
Journal:  Healthc Policy       Date:  2014

4.  Use of behavioral health care in Medicaid managed care carve-out versus carve-in arrangements.

Authors:  Christina J Charlesworth; Jane M Zhu; Marcela Horvitz-Lennon; K John McConnell
Journal:  Health Serv Res       Date:  2021-07-26       Impact factor: 3.734

5.  A pilot test of a peer navigator intervention for improving the health of individuals with serious mental illness.

Authors:  Erin Kelly; Anthony Fulginiti; Rohini Pahwa; Louise Tallen; Lei Duan; John S Brekke
Journal:  Community Ment Health J       Date:  2013-06-07

6.  Incentives and disincentives for treating of depression and anxiety in Ontario Family Health Teams: protocol for a grounded theory study.

Authors:  Rachelle Ashcroft; Matthew Menear; Jose Silveira; Simone Dahrouge; Kwame McKenzie
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

7.  Inclusion of persons with mental illness in patient-centred medical homes: cross-sectional findings from Ontario, Canada.

Authors:  Leah S Steele; Anna Durbin; Lyn M Sibley; Richard Glazier
Journal:  Open Med       Date:  2013-02-12

8.  Physician attitude toward depression care interventions: implications for implementation of quality improvement initiatives.

Authors:  Rachel Mosher Henke; Ann F Chou; Johann C Chanin; Amanda B Zides; Sarah Hudson Scholle
Journal:  Implement Sci       Date:  2008-09-30       Impact factor: 7.327

Review 9.  Incentives and disincentives for the treatment of depression and anxiety: a scoping review.

Authors:  Rachelle Ashcroft; Jose Silveira; Brian Rush; Kwame Mckenzie
Journal:  Can J Psychiatry       Date:  2014-07       Impact factor: 4.356

10.  Harm Reduction as "Continuum Care" in Alcohol Abuse Disorder.

Authors:  Icro Maremmani; Mauro Cibin; Pier Paolo Pani; Alessandro Rossi; Giuseppe Turchetti
Journal:  Int J Environ Res Public Health       Date:  2015-11-19       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.